Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Cash from Operations (2016 - 2025)

CV Sciences' Cash from Operations history spans 14 years, with the latest figure at 300000.0 for Q3 2025.

  • For Q3 2025, Cash from Operations fell 145.9% year-over-year to 300000.0; the TTM value through Sep 2025 reached 303000.0, up 62.64%, while the annual FY2024 figure was 900000.0, 139.95% down from the prior year.
  • Cash from Operations for Q3 2025 was 300000.0 at CV Sciences, down from 300000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 1411000.0 in Q2 2023 and bottomed at 3064000.0 in Q2 2021.
  • The 5-year median for Cash from Operations is 203000.0 (2024), against an average of 427210.53.
  • The largest annual shift saw Cash from Operations plummeted 542.11% in 2024 before it skyrocketed 626.32% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 1164000.0 in 2021, then skyrocketed by 118.04% to 210000.0 in 2022, then tumbled by 154.29% to 114000.0 in 2023, then tumbled by 78.07% to 203000.0 in 2024, then tumbled by 47.78% to 300000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Cash from Operations are 300000.0 (Q3 2025), 300000.0 (Q2 2025), and 100000.0 (Q1 2025).